{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:07:44Z","timestamp":1777914464043,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.euf.2025.05.017","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:29:49Z","timestamp":1748935789000},"page":"547-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prostatic Stents for the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction"],"prefix":"10.1016","volume":"11","author":[{"given":"Keiran J.C.","family":"Pace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David-Dan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiange","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Zorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem","family":"Bhojani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean S.","family":"Elterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.05.017_b0005","doi-asserted-by":"crossref","unstructured":"Elterman D, Kaplan SA. Reimagining male lower urinary tract symptoms due to benign prostatic hyperplasia treatment: a new approach to first-line interventional therapy. Eur Urol Focus. In press. https:\/\/doi.org\/10.1016\/j.euf.2024.12.008.","DOI":"10.1016\/j.euf.2024.12.008"},{"key":"10.1016\/j.euf.2025.05.017_b0010","doi-asserted-by":"crossref","unstructured":"Cerrato C, Antoniou V, Somani BK. Prostatic stents: a systematic review and analysis of functional outcomes and complication rate. Prostate Cancer Prostat Dis. In press. https:\/\/doi.org\/10.1038\/s41391-024-00915-y.","DOI":"10.1038\/s41391-024-00915-y"},{"key":"10.1016\/j.euf.2025.05.017_b0015","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s00345-023-04508-7","article-title":"A scoping review of office-based prostatic stents: Past, present, and future of true minimally invasive treatment of benign prostatic hyperplasia","volume":"41","author":"Nguyen","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.05.017_b0020","series-title":"EAU guidelines on non-neurogenic male lower urinary tract symptoms (LUTS) prostate","author":"Cornu","year":"2024"},{"key":"10.1016\/j.euf.2025.05.017_b0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003698","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023","volume":"211","author":"Sandhu","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.05.017_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5489\/cuaj.7906","article-title":"Update \u2013 2022 Canadian Urological Association guideline on male lower urinary tract symptoms\/benign prostatic hyperplasia (MLUTS\/BPH)","volume":"16","author":"Elterman","year":"2022","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euf.2025.05.017_b0035","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1464-410X.2003.04613.x","article-title":"A novel temporary prostatic stent for the relief of prostatic urethral obstruction","volume":"93","author":"Corica","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.05.017_b0040","unstructured":"SRS Medical. Use of the Spanner temporary prostatic stent as an alternative to a urinary catheter to achieve bladder drainage in men. https:\/\/clinicaltrials.gov\/study\/NCT02643849."},{"key":"10.1016\/j.euf.2025.05.017_b0045","unstructured":"Princess Al-Johara Al-Ibrahim Cancer Research Center. The Spanner prostatic stent and patient\u2019s quality of life. https:\/\/clinicaltrials.gov\/study\/NCT01705444."},{"key":"10.1016\/j.euf.2025.05.017_b0050","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.juro.2006.10.059","article-title":"A temporary intraurethral prostatic stent relieves prostatic obstruction following transurethral microwave thermotherapy","volume":"177","author":"Shore","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.05.017_b0055","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/bju.14608","article-title":"Second\u2010generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow\u2010up","volume":"123","author":"Porpiglia","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2025.05.017_b0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","article-title":"The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial","volume":"153","author":"Chughtai","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euf.2025.05.017_b0065","unstructured":"Medi-Tate Ltd. Pivotal study to assess the safety and effectiveness of the iTind device. https:\/\/clinicaltrials.gov\/study\/ NCT02506465."},{"key":"10.1016\/j.euf.2025.05.017_b0070","unstructured":"Olympus Corporation of the Americas. Post-market study to assess iTind safety in comparison to UroLift (MT-08). https:\/\/clinicaltrials.gov\/study\/ NCT04757116."},{"key":"10.1016\/j.euf.2025.05.017_b0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/end.2015.0593","article-title":"Allium\u2122 TPS\u2014a new prostatic stent for the treatment of patients with benign prostatic obstruction: the first report","volume":"30","author":"Yildiz","year":"2016","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2025.05.017_b0080","doi-asserted-by":"crossref","first-page":"e0043","DOI":"10.5041\/RMMJ.10313","article-title":"Allium stents: a novel solution for the management of upper and lower urinary tract strictures","volume":"8","author":"Bahouth","year":"2017","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.euf.2025.05.017_b0085","unstructured":"ProVerum. ProVerum announces completion of enrollment for the ProVIDE clinical study for BPH and first-use of its new flexible, steerable delivery system. Press release. March 20, 2024. https:\/\/www.prnewswire.com\/news-releases\/proverum-announces-completion-of-enrollment-for-the-provide-clinical-study-for-bph-and-first-use-of-its-new-flexible-steerable-delivery-system-302093617.html."},{"key":"10.1016\/j.euf.2025.05.017_b0090","unstructured":"ProVerum Medical. The ProVerum first in man PROVE study. https:\/\/clinicaltrials.gov\/study\/NCT03972371."},{"key":"10.1016\/j.euf.2025.05.017_b0095","unstructured":"ProVerum Medical. ProVee urethral expander system IDE study (ProVIDE). https:\/\/clinicaltrials.gov\/study\/NCT05186740."},{"key":"10.1016\/j.euf.2025.05.017_b0100","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41391-022-00548-z","article-title":"The Expander-1 trial: introduction of the novel Urocross\u2122 expander system for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)","volume":"25","author":"Woo","year":"2022","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2025.05.017_b0105","unstructured":"Prodeon Medical Inc. Expander-2 trial: randomized study to evaluate safety & efficacy of the Urocross\u2122 expander system & retrieval sheath. https:\/\/clinicaltrials.gov\/study\/NCT05400980."},{"key":"10.1016\/j.euf.2025.05.017_b0110","unstructured":"MedeonBio Inc. Safety and feasibility of the XFLO expander system (Mercury) (EXPANDER-1). https:\/\/clinicaltrials.gov\/study\/NCT03758222."},{"key":"10.1016\/j.euf.2025.05.017_b0115","first-page":"10580","article-title":"Is it time to offer true minimally invasive treatments (TMIST) for BPH? A review of office-based therapies and introduction of a new technology category","volume":"28","author":"Elterman","year":"2021","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2025.05.017_b0120","unstructured":"Broderick JM. Study: Zenflow Spring System for BPH does not negatively impact sexual health. Urology Times. June 24, 2024. https:\/\/www.urologytimes.com\/view\/study-zenflow-spring-system-for-bph-does-not-negatively-impact-sexual-health."},{"key":"10.1016\/j.euf.2025.05.017_b0125","unstructured":"Zenflow Inc. The Zenflow Spring System safety, performance and effectiveness study (ZEST2). https:\/\/clinicaltrials.gov\/study\/NCT03595735."},{"key":"10.1016\/j.euf.2025.05.017_b0130","unstructured":"Zenflow Inc. The Zenflow Spring System EU safety and performance study (ZEST EU). https:\/\/clinicaltrials.gov\/study\/NCT03577236."},{"key":"10.1016\/j.euf.2025.05.017_b0135","unstructured":"Zenflow Inc. Safety and effectiveness study of the Zenflow Spring System (BREEZE). https:\/\/clinicaltrials.gov\/study\/NCT04987138."},{"key":"10.1016\/j.euf.2025.05.017_b0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000528415","article-title":"The Butterfly: a novel minimally invasive transurethral retraction device for benign hypertrophy of the prostate","volume":"107","author":"Katz","year":"2023","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2025.05.017_b0145","unstructured":"Butterfly Medical. Pilot study to assess the safety and efficacy of Butterfly Medical prostatic retraction device in BPH patients. https:\/\/clinicaltrials.gov\/study\/NCT03912558."},{"key":"10.1016\/j.euf.2025.05.017_b0150","unstructured":"Rivermark Medical. Early feasibility clinical study of the FloStent\u2122 system. https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=386010."},{"key":"10.1016\/j.euf.2025.05.017_b0155","unstructured":"Rivermark medical. Rivermark Medical Announces fully enrolled multi-center OUS clinical trial for innovative benign prostatic hyperplasia device. Press release. December 7, 2023. https:\/\/www.rivermarkmedical.com\/press-release\/rivermark-medical-announces-fully-enrolled-multi-center-ous-clinical-trial-for-innovative-benign-prostatic-hyperplasia-device."},{"key":"10.1016\/j.euf.2025.05.017_b0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.purol.2022.04.012","article-title":"Feasibility of EXIME\u00ae temporary prosthesis placement and removal in men with acute or chronic urinary retention after failure or inability to selfcatheterize","volume":"32","author":"Charbonnel","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2025.05.017_b0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.23736\/S2724-6051.21.04316-2","article-title":"Rezum procedure with Exime\u00ae stent: a step forward to micro-invasiveness","volume":"73","author":"Cindolo","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"10.1016\/j.euf.2025.05.017_b0170","unstructured":"Lyx Institute. To evaluate LUTS and complications between indwelling catheter and temporary prostatic stent in patients undergoing minimally invasive procedures for the treatment of localized prostate cancer or benign prostatic hyperplasia (HERMES). https:\/\/clinicaltrials.gov\/study\/NCT05851521."}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925001488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925001488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:24:53Z","timestamp":1764321893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925001488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2405456925001488"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.05.017","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostatic Stents for the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}